Element Solutions Inc Announces Acquisition of DMP Corporation and the Launch of MacDermid Envio Solutions

MIAMI–(BUSINESS WIRE)– Element Solutions Inc (NYSE:ESI) (“Element Solutions” “ESI” or the “Company”), a global and diversified specialty chemicals company, today announced its acquisition of DMP Corporation (“DMP”), a premier provider of turnkey wastewater treatment and recycle and reuse solutions across multiple manufacturing industries. The Company today also announced the formation of MacDermid Envio Solutions, a new business focused on helping customers profitably reduce their environmental impact through proprietary water treatment and metals recycling solutions. This business will report under Element Solutions’ Industrial Solutions vertical but sell across ESI’s broader end markets. The acquisition of DMP further expands the Company’s investment in technology to provide innovative solutions helping its customers manage the existential issue of sustainability for manufacturing businesses around the world. DMP will be combined with ESI’s existing Chemtech metals recycling business to form MacDermid Envio Solutions.

Executive Commentary

Chief Executive Officer Benjamin Gliklich said, “As environmental concerns and regulation continue to drive change within the specialty chemicals industry and our existing supply chain, we continue to invest in technology to help our customers meet and exceed these requirements. The acquisition of DMP and formation of MacDermid Envio Solutions allow Element Solutions to offer its customers capabilities that are both needed today and will be needed more over time. DMP’s existing footprint is in North America, but its technology is relevant around the world. There is a great growth opportunity in taking this business to our global customer base. Environmental matters are existential for our customers, and we are excited to help provide them with yet another set of critical solutions. We are very happy to welcome the DMP team into the ESI family.”

Mr. Gliklich continued, “MacDermid Envio Solutions will launch with a modest $20 million of annual sales; however, we have greater ambitions for it in the near term. The solutions we provide require minimal investment and have short payback periods for our customers, in addition to the significant benefit for our planet. Several of the technologies in this portfolio are novel to international markets and with modest customer education, these technologies should generate strong traction. Sales into this market will be completely additive to the existing Element Solutions businesses and a growth driver for our company. MacDermid Envio Solutions will be a case study in doing well by doing good.”

About Element Solutions

Element Solutions Inc is a leading global specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. Developed in multi-step technological processes, the innovative solutions of the Company’s businesses enable customers’ manufacturing processes in several key industries, including electronic circuitry, semiconductor, communications infrastructure, automotive systems, industrial surface finishing, consumer packaging and offshore energy.

More information about the Company is available here.

About DMP Corporation

Founded in 1971, DMP Corporation is a leading provider of efficient, cost-effective wastewater treatment and recycle and reuse solutions. As an ISO 9001:2015 certified chemical manufacturer, DMP offers a broad selection of manufacturing proprietary chemicals and equipment that provide effective and comprehensive solutions tailored to customers’ needs across a variety of industries.

More information about the Company is available here.

About MacDermid Envio Solutions

Combining intimate chemistry know-how and advanced engineering solutions, MacDermid Envio Solutions provides equipment, chemistry and services that improve its customers’ environmental footprints through wastewater treatment and materials recycling solutions. Custom solutions from MacDermid Envio Solutions reduce customers’ waste discharge and save them money.

More information about the Company is available here.

Element Solutions and MacDermid Envio Solutions are Trademarks of Element Solutions Inc and its subsidiaries.

Contact Information

Investor Relations Contact:
Yash Nehete
Associate Director, Corporate Development & IR
Element Solutions Inc
1-561-406-8465

Media Contact:
Liz Cohen

Managing Director
Kekst CNC
1-212-521-4845

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More